Abstract:Background/Introduction Newly diagnosed atrial fibrillation (AF) frequently occurs during acute coronary syndrome (ACS). In contrast to known AF, little is known about the prognostic and therapeutic implications of new AF. Purpose To evaluate the prognostic impact of newly diagnosed and known AF in patients with ACS. Furthermore, we evaluated the association of episode characteristics of new AF with clinical outcomes: early vs late occurrence, short vs long duration, post-CABG occurrence, and OAC treatment. Methods This analysis was performed within the prospective, multicentre, FORCE-ACS registry which studies ACS patients in the Netherlands. All ECGs during index ACS admission were retrospectively examined for the occurrence of AF. Patients were classified as no, new, or known AF. New AF episodes were described regarding early or late occurrence, duration of the episode, and post-CABG occurrence, and OAC prescription at discharge was evaluated. The primary outcome was MACE, a composite of death, myocardial infarction and stroke. Secondary outcomes include the separate MACE components and bleeding. Crude and adjusted outcomes were evaluated by univariable and multivariable Cox regression. Results 3902 patients were included of which 299 (10.2%) had new and 367 (9.4%) had known AF. Major adverse cardiac events happened significantly more in both new and known AF patients than in patients without AF (22.2%, 17.4%, and 9.2%, p<0.001). Ischemic stroke occurred significantly more in new AF but not in known AF patients, compared to patients without AF (3.5% vs 0.9% vs 1.1%). After one year follow-up, a total of 234 patients (6.3%) deceased, of whom 138 in the group without AF (4.6%), and significantly more in the groups with new AF (n=59, 15.9%), and known AF (n=37, 10.8%). The timing of onset of the AF episode showed no significant association with clinical outcomes. Longer duration of the episode, however, was associated with increased MACE (HR 2.0, 95% CI 1.2–3.1) and all-cause mortality (HR 2.0, 95% CI 1.2–3.4). Episodes of new AF that occurred post-CABG were associated with less MACE (HR 0.31, 95% CI 0.14–0.67) and all-cause mortality (HR 0.20, 95% CI 0.07–0.55). No significant association between OAC treatment and MACE nor any of its separate components was found. Conclusion Newly diagnosed atrial fibrillation in acute coronary syndromes is associated with worse clinical outcomes than known or no atrial fibrillation. Longer episodes were associated with worse outcomes than short episodes. Post-operative new AF was associated with better outcomes than non-post-operative new AF. Funding Acknowledgement Type of funding sources: None.

Clinical outcomes of atrial high-rate episodes: an updated meta-analysis

Association of device-detected atrial high-rate episodes with long-term cardiovascular and all-cause mortality: a cohort study

Role of atrial high-rate episodes in stratifying thromboembolic risk: a multiple cut-off diagnostic meta-analysis

Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices

Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions

Management of atrial arrhythmias identified by cardiac devices

Progression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality

Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices

Abstract 14262: Atrial Fibrillation Burden and Clinical Outcomes in Patients With Cardiac Implanted Electronic Devices

Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta‐analysis

Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis

Association of device detected atrial and ventricular tachyarrhythmia with adverse events in patients with an implantable cardioverter‐defibrillator

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

Prognostic impact of newly diagnosed atrial fibrillation and episode characteristics in patients with acute coronary syndrome

The incidence and risk factors of atrial high-rate episodes in patients with a dual-chamber pacemaker

Mid-to-long-term recurrence of atrial fibrillation in surgical treatment vs . catheter ablation: a meta-analysis using aggregated survival data

Comparative Analysis of Clinical Outcomes of High-power, Short-duration Ablation versus Low-power, Long-duration Ablation Strategy in Patients with Atrial Fibrillation: A Comprehensive Umbrella Review of Meta-analyses

Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis

Interventions for the treatment of atrial fibrillation: a systematic literature review and meta-analysis

Associations Between Changes in Maximum Daily Atrial Fibrillation Duration, Ischemic Stroke, and Mortality